Literature DB >> 18696274

Genetic variation in the alpha 7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's disease.

Robyn Carson1, David Craig, Dominic Hart, Stephen Todd, Bernadette McGuinness, Janet A Johnston, Francis A O'Neill, Craig W Ritchie, A Peter Passmore.   

Abstract

Psychotic symptoms are common in Alzheimer's disease (AD) and have a negative impact on quality of life. It is suggested that psychotic symptoms may be attributed to genetic risk factors which are revealed during neurodegeneration. CHRNA7, the gene for the alpha 7 nicotinic acetylcholine receptor, has been associated with schizophrenia in linkage and association studies. Hence we investigated single SNPs and haplotypes in CHRNA7 in relation to AD with psychosis in a large, well-characterised and previously described cohort within the Northern Ireland population. A significant association between delusions and the T allele of rs6494223 (P = 0.014, OR = 1.63, CI = 1.22-2.17) was found. This suggests that the alpha 7 receptor may be a suitable target for the treatment of AD with psychosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18696274     DOI: 10.1007/s12017-008-8048-8

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  51 in total

1.  A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.

Authors:  H Feldman; S Gauthier; J Hecker; B Vellas; P Subbiah; E Whalen
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

2.  Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release.

Authors:  Lifen Zhang; Fu-Ming Zhou; John A Dani
Journal:  Mol Pharmacol       Date:  2004-09       Impact factor: 4.436

3.  Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia.

Authors:  Sherry Leonard; Judith Gault; Jan Hopkins; Judith Logel; Ruby Vianzon; Margaret Short; Carla Drebing; Ralph Berger; Diana Venn; Pinkhas Sirota; Gary Zerbe; Ann Olincy; Randal G Ross; Lawrence E Adler; Robert Freedman
Journal:  Arch Gen Psychiatry       Date:  2002-12

4.  Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses.

Authors:  Rodney C P Go; Rodney T Perry; Howard Wiener; Susan S Bassett; Deborah Blacker; Bernie Devlin; Robert A Sweet
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-11-05       Impact factor: 3.568

Review 5.  Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003.

Authors:  Susan A Ropacki; Dilip V Jeste
Journal:  Am J Psychiatry       Date:  2005-11       Impact factor: 18.112

6.  Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.

Authors:  R A Sweet; B Devlin; B G Pollock; D L Sukonick; K B Kastango; S-A Bacanu; K V Chowdari; S T DeKosky; R E Ferrell
Journal:  Mol Psychiatry       Date:  2005-11       Impact factor: 15.992

Review 7.  Neuronal nicotinic receptors: from structure to pathology.

Authors:  C Gotti; F Clementi
Journal:  Prog Neurobiol       Date:  2004-12       Impact factor: 11.685

8.  Alpha-7 nicotinic acetylcholine receptor agonists selectively activate limbic regions of the rat forebrain: an effect similar to antipsychotics.

Authors:  Henrik H Hansen; Daniel B Timmermann; Dan Peters; Carrie Walters; M Imad Damaj; Jens D Mikkelsen
Journal:  J Neurosci Res       Date:  2007-06       Impact factor: 4.164

9.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

Review 10.  Causative and susceptibility genes for Alzheimer's disease: a review.

Authors:  A Rocchi; S Pellegrini; G Siciliano; L Murri
Journal:  Brain Res Bull       Date:  2003-06-30       Impact factor: 4.077

View more
  12 in total

1.  Axonal α7 nicotinic ACh receptors modulate presynaptic NMDA receptor expression and structural plasticity of glutamatergic presynaptic boutons.

Authors:  Hong Lin; Stefano Vicini; Fu-Chun Hsu; Shachee Doshi; Hajime Takano; Douglas A Coulter; David R Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-03       Impact factor: 11.205

Review 2.  The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function.

Authors:  Melissa L Sinkus; Sharon Graw; Robert Freedman; Randal G Ross; Henry A Lester; Sherry Leonard
Journal:  Neuropharmacology       Date:  2015-02-19       Impact factor: 5.250

Review 3.  Genetics of psychosis in Alzheimer's disease: a review.

Authors:  Mary Ann DeMichele-Sweet; Robert A Sweet
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 4.  Neurobiology of delusions in Alzheimer's disease.

Authors:  Zahinoor Ismail; Minh-Quan Nguyen; Corinne E Fischer; Tom A Schweizer; Benoit H Mulsant; David Mamo
Journal:  Curr Psychiatry Rep       Date:  2011-06       Impact factor: 5.285

5.  The neural signatures of psychoses in Alzheimer's disease: a neuroimaging genetics approach.

Authors:  Riccardo Manca; Antonio F Pardiñas; Annalena Venneri
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-06-21       Impact factor: 5.270

6.  Homology Modeling and Protein Interaction Map of CHRNA7 Neurogenesis Protein.

Authors:  Ruchi Yadav; Deepshikha Deepshikha; Prachi Srivastava
Journal:  Ann Neurosci       Date:  2017-07-24

Review 7.  APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.

Authors:  Susan Bookheimer; Alison Burggren
Journal:  Annu Rev Clin Psychol       Date:  2009       Impact factor: 18.561

8.  Genetics of Psychosis in Alzheimer Disease.

Authors:  Mary Ann A DeMichele-Sweet; Robert A Sweet
Journal:  Curr Genet Med Rep       Date:  2014-03

9.  α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease.

Authors:  Jun Toyohara; Kenji Hashimoto
Journal:  Open Med Chem J       Date:  2010-05-27

10.  α7 and β2 Nicotinic Acetylcholine Receptor Subunits Form Heteromeric Receptor Complexes that Are Expressed in the Human Cortex and Display Distinct Pharmacological Properties.

Authors:  Morten Skøtt Thomsen; Ruud Zwart; Daniel Ursu; Majbrit Myrup Jensen; Lars Hageman Pinborg; Gary Gilmour; Jie Wu; Emanuele Sher; Jens Damsgaard Mikkelsen
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.